An Analysis of Chinese Publicly Listed Pharmaceutical Company CSR Disclosures

Mert Demir, Terrence F. Martell and Qian Zhuang
Additional contact information
Mert Demir: Weissman Center for International Business, Baruch College, City University of New York, New York, NY, USA
Terrence F. Martell: Weissman Center for International Business, Baruch College, City University of New York, New York, NY, USA
Qian Zhuang: School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, Jiangsu Province 211198, China

Review of Pacific Basin Financial Markets and Policies (RPBFMP), 2024, vol. 27, issue 03, 1-50

Abstract: Increased public awareness toward Corporate Social Responsibility (CSR) has intensified the pressure on the pharmaceutical industry to adopt more responsible practices. As a top supplier of Western pharmaceutical companies, Chinese pharmaceutical companies are not immune to these same pressures as they engage with overseas regulators and investors. This study analyzes the factors that contribute to the CSR disclosures of publicly listed Chinese pharmaceutical companies covering 2014–2018. In the analysis, peer comparison and market-driven incentives to disclose a firm’s CSR impacts and risks come out as a robust determinant of overall disclosure and its components. While stakeholder awareness and strategic CSR have some varying degrees of associations with the five pillars of CSR disclosures, institutional framework and spill-over effect seem to have only limited influence on these disclosures. The results highlight some interesting dynamics and can provide insights into the implications of fostering a CSR-oriented business culture.

Keywords: Corporate social responsibility; CSR disclosure; pharmaceutical industry; CSR performance; state-owned enterprises (search for similar items in EconPapers)
Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.worldscientific.com/doi/abs/10.1142/S021909152450022X
Access to full text is restricted to subscribers

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wsi:rpbfmp:v:27:y:2024:i:03:n:s021909152450022x

Ordering information: This journal article can be ordered from

DOI: 10.1142/S021909152450022X

Access Statistics for this article

Review of Pacific Basin Financial Markets and Policies (RPBFMP) is currently edited by Cheng-few Lee

More articles in Review of Pacific Basin Financial Markets and Policies (RPBFMP) from World Scientific Publishing Co. Pte. Ltd.
Bibliographic data for series maintained by Tai Tone Lim ().